Kristian Werling, Kevin Miller, Larry Guess and Richard Smith were the McDermott lawyers who represented Baxter International Inc. in a licensing agreement it reached with Merrimack Pharmaceuticals Inc. The agreement gives Baxter exclusive rights to develop and commercialize outside of the U.S. and Taiwan an investigative treatment for pancreatic cancer.
We use cookies to improve the functionality and performance of this site. By continuing to use this site, you are providing us with your consent to our use of cookies. Please see our Privacy Policy for details.